At Bristol Myers Squibb, we are inspired by a single vision transforming patients lives through science. In oncology, hematology, immunology and cardiovascular disease and one of the most diverse and promising pipelines in the industry each of our passionate colleagues contribute to innovations that drive meaningful change. We bring a human touch to every treatment we pioneer. Join us and make a difference.
Job Summary:
This position analyzes chargeback data and maintains accurate processing data. The role is responsible for the daily processing of chargeback, communication with our customers, and reconciliation of accounts receivables.
Job Description
* Processes, monitors, reports, audits and reviews chargeback data and information.
* Proactively analyzes chargeback data to uncover issues, identify trends, and to develop and propose potential solutions for approval by management.
* Analyzes, evaluates, and applies critical thinking and business acumen to ensure proper handling of each issue and/or document.
* Utilizes all available techniques and sources to work with the assigned wholesaler to minimize financial deductions and disputes.
* Monitors all wholesaler deductions and fully documents the entire collections process.
* Evaluates assigned accounts, tasks or functions and constantly works to improve processes and services to the business.
* Demonstrates strong computer software technical skills.
* Uses Model N, SAP and Microsoft Office products including Word, Excel, Access and other tools to help perform the requirements of the position.
* Demonstrates strong evaluation skills when working with wholesaler data to provide root cause analysis of chargeback denials and related issues.
* Coordinates, hosts and runs meetings while articulating information to peers and management.
* Performs frequent ad hoc analysis of customer, pricing, contract eligibility and chargeback issues.
Desired Experience:
* A minimum of 5 years of related experience in one of the following: business analysis, financial analysis, audit, contract administration, or master data administration.
* Experience with analytical techniques to determine reasonableness of data, trends, and root cause of issues.
* Strong organizational skills, effective communication skills with both internal and external partners, and the ability to work well across a matrix team are required.
* Ability to work with remote business partners.
* Experience with SAP and Model N, or similar systems, is preferred.
* Demonstrated experience with the Microsoft Office suite.
* Pharmaceutical industry experience is preferred.
* Bachelors Degree or equivalent experience
Travel Required:
0%
Around the world, we are passionate about making an impact on the lives of patients with serious diseases. Empowered to apply our individual talents and diverse perspectives in an inclusive culture, our shared values of passion, innovation, urgency, accountability, inclusion and integrity bring out the highest potential of each of our colleagues.
Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives.
Summit, NJ
Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of cancer and inflammatory diseases worldwide. It offers REVLIMID, an oral immunomodulatory drug for multiple myeloma (MM), myelodysplastic syndromes (MDS), and mantle cell lymphoma; POMALYST/IMNOVID to treat multiple myeloma; OTEZLA, a small-molecule inhibitor of phosphodiesterase 4 for psoriatic arthritis and psoriasis; and ABRAXANE to treat breast, non-small cell lung, pancreatic, and gastric cancers.
The company’s products also include IDHIFA for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (rrAML) with an isocitrate dehydrogenase-2 mutation; VIDAZA, a pyrimidine nucleoside analog for intermediate-2 and high-risk MDS, chronic myelomonocytic leukemia, and AML; THALOMID to treat patients with MM; and ISTODAX, an epigenetic modifier. Its preclinical and clinical-stage product candidates include small molecules, biologics, and cell therapies for immune-inflammatory diseases, myeloid diseases, epigenetics, protein homeostasis, and immuno-oncology.
The company has agreements with BeiGene, Ltd; Acceleron Pharma, Inc.; Agios Pharmaceuticals, Inc.; bluebird bio, Inc.; Lycera Corp.; Juno Therapeutics, Inc.; EXSCIENTIA LTD.; and IMIDomics SL, as well as immuno-oncology collaboration with Sutro Biopharma. Celgene Corporation was founded in 1980 and is headquartered in Summit, New Jersey.